Baroreflex activation therapy with the Barostim device from CVRx has received new CPT codes from the American Medical Association. The codes go into effect in January 2026.

The premixed embolic agent is designed to embolize hypervascular tumors and occlude blood flow in a patient's peripheral blood vessels. It was recalled in April due to safety concerns.

In a letter, the undersigned asked Congress to halt cuts to Medicare reimbursement and enact a permanent system to adjust rates to inflation. 

STS designed these new mobile-friendly resources with updated data and modern surgical techniques in mind.

Imaging plays an essential role in addressing hepatic steatosis. Yet, radiologists have had almost zero involvement in shaping medical knowledge about the disease. 

Google is shaking things up at the top ... and making Google Cloud’s healthcare AI goodies more widely available. 

The U.S. Food and Drug Administration has its hands full making sure medical AI products are safe, efficacious and trustworthy before they hit the market. The rise of ever-more-innovative iterations of the technology—not least generative AI—is only adding to the burden. 

The Texas Hospital Association said answering the question, which stems from an executive order from Gov. Greg Abbot, will not impact patient care.